Effervescent Tablet Global Market Report 2024

The global effervescent tablet market has grown strongly in recent years. It will grow from $33.49 billion in 2023 to $36.82 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historical period can be attributed to early pharmaceutical innovations, advancements in medical technology, the emergence of consumer health trends, consumer convenience and preference, as well as effective marketing and branding strategies.

The global effervescent tablet market is expected to see rapid growth in the next few years. It will grow to $54.94 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The projected growth in the forecast period can be attributed to the preference for convenient dosage forms, ongoing innovation in formulations, increasing consumer demand for novel products, endorsements from healthcare professionals, and demographic shifts. Key trends expected in this period include changes in market value structure, identification of cost drivers, growth rate patterns, advancements in sales channels, and technological innovations within the industry.

The high prevalence rate of chronic diseases is a significant driver propelling the growth of the effervescent tablets market. Chronic diseases, such as cancer, heart disease, stroke, diabetes, and arthritis, are characterized by their prolonged duration and potential to worsen over time. Effervescent tablets play a crucial role in the treatment of chronic illnesses, serving as potent antioxidants that elevate blood antioxidant levels and help reduce the risk of these diseases. In the US alone, it is anticipated that there will be 609,360 cancer deaths and 1.9 million new cancer cases in 2022, emphasizing the widespread impact of chronic diseases. This prevalence is a key factor driving the increased adoption of effervescent tablets in healthcare.

The rise in the geriatric population is expected to contribute significantly to the growth of the effervescent tablet market. As the percentage of individuals aged 65 and older continues to increase globally, there is a growing market opportunity for effervescent tablets. This demographic seeks healthcare solutions that cater to their distinctive needs, and effervescent tablets provide formulation advantages, user-friendly administration, and customization options. According to the World Health Organization (WHO), by 2030, one in six people globally will be 60 or older, with the population of individuals aged 80 or older projected to increase by 426 million between 2020 and 2050. The aging population's unique healthcare requirements make effervescent tablets an appealing choice, driving market growth.

Technological advancements represent a key trend shaping the effervescent tablet market. Major players in the market are actively focusing on innovative manufacturing technologies to maintain a competitive edge. For instance, Health Innovations Ltd., a UK-based healthcare supplement manufacturing company, introduced EfferShield technology. This patented technology for effervescent pills and powders offers consumers more flexible and convenient packaging options, including single-use pouches and stick-pack packaging. The introduction of such advanced technologies enhances the overall appeal and convenience of effervescent tablets, contributing to market growth.

Major companies in the effervescent tablet market are investing in the development of innovative products, including filler binders, to cater to larger customer bases and increase revenue. Filler binders, such as Beneo's galenIQ 721, play a crucial role in pharmaceuticals by providing cohesion and aiding in the compression of powders into solid dosage forms like tablets or capsules. Beneo's galenIQ 721, launched in October 2021, stands out for its ability to enhance taste and stability in effervescent tablets and powders. As a non-hygroscopic, water-soluble, and directly compressible excipient, it ensures high content uniformity and production efficiency, meeting the evolving demands of the effervescent tablet market.

In July 2021, Nestlé Health Science, a Switzerland-based provider of nutritional solutions, successfully acquired Nuun for an undisclosed amount. This strategic acquisition underscores the shared commitment of both companies to advance Nuun's mission. The focus is on steering the company towards a future characterized by an expanded range of high-quality hydration products and a significant impact on social and cultural fronts. Nuun, known for its effervescent tablets and powders, continues its operations from its headquarters in Seattle, Washington.

Major companies operating in the effervescent tablet market report are Bayer AG, Hermes Arzneimittel GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Bristol-Myers Squibb Company, Bliss GVS Pharma Limited, Herbalife International Inc., Amerilab Technologies Inc., Pfizer Inc., Novartis AG, Perrigo Company PLC, Chiesi Farmaceutici SpA, SG Biopharm Pvt. Ltd., Advanced Enzyme Technologies Limited, Vovantis Laboratories Pvt. Ltd., Nutrilo GmbH, Tower Laboratories Ltd., Losan Pharma GmbH, American Health, BioVit GMP Laboratories Limited, By-health Co. Ltd., Vitabiotics Ltd., Prestige Brands Inc., Nuun and Company Inc., DMK Group, Amway Corp, GNC Holdings Inc., Sanofi SA, Merck KGaA, Roche Holding AG, Johnson & Johnson, Procter & Gamble Co., Unilever PLC, Nestle SA, PepsiCo Inc., The Coca-Cola Company, and Dr Reddy's Laboratories Ltd.

North America was the largest region in the effervescent tablets market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the effervescent tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the effervescent tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The main categories of effervescent tablets include medication and supplements. Medications encompass drugs and medical preparations used to treat various biological abnormalities and illnesses. The preparation methods for effervescent tablets include dry methods and wet granulation. These tablets are utilized for a range of indications, including diuretics, pain management, gastric disorders, respiratory diseases, and more. They find applications in dental products, dietary supplements, pharmaceuticals, and other areas. Effervescent tablets are used by various end-users such as hospitals, specialty clinics, home care, and others.

This report provides effervescent tablets market statistics, including effervescent tablets industry global market size, regional shares, competitors with an effervescent tablets market share, detailed effervescent tablets market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent tablets industry. This effervescent tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The effervescent tablet market consists of sales of prescription-based tablets and daily-used tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.